Abstract: Pet food compositions as well as method for alleviating pruritus, erythema, alopecia, or skin and ear secretion are disclosed herein. The pet food composition may comprise from about 1 to about 10 wt. % of quinoa; from about 1 to about 10 wt. % of amaranth; and from about 0.5 to about 8 wt. % of egg shell membrane, wherein all weight percentages are based on the total weight of the pet food composition on a dry matter basis.

Abstract: Methods of identifying a dog as having deficient nucleic base salvage and methods of identifying a dog as being at an elevated risk and increased likelihood of developing immune dysfunction are disclosed. Methods of treating a dog to prevent, delay onset of or reduce severity of symptoms of immune dysfunction in the dog and methods of treating a dog diagnosed with or suspected of having immune dysfunction are disclosed. Methods of treating a dog diagnosed with or suspected of having immune dysfunction are disclosed. The disclosed methods include performing a genetic analysis of the dog to detect the presence of 2 copies of major allele G for single nucleotide polymorphism Affx-205876096. Nutritionally complete and balanced dog food compositions are disclosed. The nutritionally complete and balanced dog food compositions comprise a therapeutic level of nucleotides.

Abstract: A system, apparatus, and/or method of determining a health condition of an animal is provided. First data may be received from a first sensor device. The first data may be indicative of an animal event of an animal. Second data may be received from a second sensor device. The second sensor may be separate and/or distinct from the first sensor device. The second data may confirm an occurrence of the animal event. The animal event may be a discharge event and/or a feeding event. The occurrence of the animal event may be identified based on the first data and the second data. The occurrence of the animal event may be displayed via a display device. A health condition of the animal may be determined based on the animal event. The determination of the health condition may be based on a quantity and/or a duration of the animal event.

Abstract: Methods of detecting the presence of one copy or 2 copies of a minor allele of one or more single nucleotide polymorphisms selected from the group consisting of SNP A3_117040611, SNP A3_117041908 and SNP A3_117081913 are disclosed. Methods of identifying a feline subject as being at an increased likelihood of developing cat kidney disease are disclosed. Methods of monitoring the health of a feline subject identified as having an increased likelihood of developing CKD are provided. Methods of monitoring the health of a feline subject and response to treatment for renal disease that comprise quantifying at 2PY present are provided. Methods of delaying onset and severity of cat kidney disease in a feline subject identified as having an increased likelihood of developing CKD and methods of treating cats that have CKD are provided.

Abstract: The present disclosure is directed to a method for reducing immunoreactivity of a food including (a) incubating a food that contains at least one protein with a cross-linking enzyme to form a food that includes at least one cross-linked protein; and (b) fermenting the food including the at least one cross-linked protein with a microorganism to form a modified food including a hydrolysate of the at least one cross-linked protein, wherein (a) is performed before (b) and wherein a level of immunoreactivity of the modified food is less than a level of immunoreactivity of an unmodified food including at least one protein. Modified foods obtained from the present method are also provided.

Abstract: Described herein are systems and methods for tracking an animal comprising—for example: an electronic device configured to be implanted within an animal and comprising: one or more sensors configured to determine information relating to the animal; a memory device configured to store the information relating to the animal; a communication interface configured to wirelessly and transcutaneously communicate the information to an external device according to predetermined priority rules; and a battery device for providing power to at least one of the one or more sensors or the communication interface.

Abstract: Described herein are systems and methods for tracking an animal comprising—for example: an electronic device configured to be coupled to an animal, the electronic device comprising: one or more sensors comprising at least one of an accelerometer, a gyroscope, or a magnetometer, the one or more sensors configured to determine location or movement information relating to the animal; a memory device configured to store the location or movement information relating to the animal; a communication interface configured to wirelessly communicate the location or movement information to an external device; and a battery device for providing power the at least one of the one or more sensors or the communication interface; and a charging device configured to wirelessly provide power to the battery device.

Abstract: Described herein are systems and methods for monitoring an animal comprising: an electronic device configured to be implanted within an animal, the electronic device comprising: one or more sensors comprising at least one of an accelerometer, a gyroscope, or a magnetometer, the one or more sensors configured to determine location or movement information relating to the animal; a memory device configured to store the location or movement information relating to the animal; a communication interface configured to wirelessly communicate the location or movement information to an external device; and a battery device for providing power to at least one of the one or more sensors or the communication interface.

Abstract: The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.

Abstract: A method, device, and system for determining a body attribute of an animal may be provided. For example, a system may include a sensor configured to capture image data relating to the animal. One or more processors may be configured to receive the captured image data relating to the animal; identify portions relating to the animal depicted within the image data; input, into a machine learning model, the portions relating to the animal depicted within the image data; and determine, via the machine learning model, an ideal body weight (IBW), a body condition score (BCS) of the animal, a body fat index (BFI) of the animal, a weight or other attributes of the animal or part of the animal including height, width, length, depth, diameter, radius, circumference, and the like.

Abstract: Described herein are controlled release pet food compositions comprising: a matrix comprising: a fiber component comprising a high solubility fiber source and low solubility fiber source, and a polyphenol source; wherein the matrix is adapted to deliver the polyphenol source to the lower gastrointestinal (GI) tract of a mammal after ingestion by the mammal. Methods of making and using these compositions are also described.

Abstract: Described herein are pet food compositions comprising—in relevant part—effective amounts of betaine and carnitine. Methods of making and using these compositions are also described.

Abstract: Methods of identifying canine subjects having an increased likelihood of developing elevated levels of 4-ethylphenyl sulfate, canine stress, canine anxiety and/or an inhibition of growth of beneficial microbes and promotion of growth of harmful microbes are disclosed. Methods comprise analyzing a biological sample obtained from the canine subject for the presence of two copies of a minor allele of the single nucleotide polymorphism BICF2P1175095 in a canine subject. Methods of treating the identified canine subjects by administering an effective amount of tomato pomace are also disclosed. Methods of treating canine subjects for elevated 4-EPS levels, canine anxiety or canine stress are disclosed. Canine food compositions that comprises tomato pomace are disclosed.

Abstract: Methods of analyzing a biological sample obtained from the canine subject for the presence of one or two copies one or two copies of minor allele T of SNP Affx-206229307; or one or two copies of minor allele A of SNP Affx-206560187; or one or two copies of minor allele T of SNP Affx-206229307 and one or two copies of minor allele A of SNP Affx-206560187 are disclosed. The methods are used in methods to identify a canine subject that has an increased likelihood or risk of hypothyroidism and in methods of treating a canine subject to reduce risk of hypothyroidism or to treat a canine subject that has hypothyroidism. The treatments comprise administering to the canine subject a low arginine diet and/or comprising an effective amount of a composition comprising a protein source, a carbohydrate source, a vegetable source, and a fruit source. Canine food compositions are disclosed.

Abstract: Methods and kits for assessing the propensity of developing urolithiasis, kidney disease, or bladder disease in pets; and compositions to treat such conditions are described herein.

Abstract: Described herein are pet food compositions comprising—in relevant part—neutral detergent fiber and crude fiber in amounts, which are effective in inducing satiety and supporting healthy weight management. Methods of making and using these pet food compositions are also described.

Abstract: Described herein are pet food compositions comprising greater than 35 wt. % fat, greater than 10 wt. % fiber, protein, low levels of carbohydrates, and a ketogenic ratio greater than or equal to 1.5. Methods of making and using these pet food compositions are also described herein.

Abstract: The present invention encompasses pet food compositions that include one or more probiotic microorganisms, which are useful to improve the health of companion animals. For example, the invention encompasses pet food compositions including a probiotic, for example, Lactobacillus, Bifidobacterium and Streptococcus (Enterococcus). The present invention also encompasses the preparation of pet food compositions including one or more probiotic microorganisms intended for methods of maintaining or improving pet health through feeding a pet a pet food composition including the probiotic microorganism.

Abstract: Compositions and methods of treating anxiety or stress in an animal are disclosed. Compositions and methods of reducing or preventing elevated levels of 4-EPS are disclosed. Compositions and methods for promoting growth of beneficial microbes in an animal's microbiome and inhibiting growth of non-beneficial microbes are disclosed. The methods comprise administering to the animal an effective amount of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber. Compositions comprise effective amounts of n-3 fatty acids, antioxidants, insoluble fiber and soluble fiber in an effective ratio of insoluble fiber and soluble fiber.